Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population

NCT02316522 is registered in ClinicalTrials.gov with Weill Medical College of Cornell University as lead sponsor.

NCT NCT02316522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02316522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Epigenetic Contribution to the Pathogenesis of Diabetic Nephropathy in Qatari Population
Lead sponsor
Weill Medical College of Cornell University
Phase
Observational
Overall status
Completed
Start date
October 23, 2014
Completion date
April 9, 2018
Enrollment
158 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes